KORU Medical Systems (KRMD) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Neuronetics (STIM) has outperformed KORU Medical Systems (KRMD) over the past year, losing 4.6% versus a loss of 33.3%. Over five years, KRMD leads with a -12.6% price change compared with -69.7% for STIM. KORU Medical Systems is the larger company by market cap ($138.4 million vs $120.6 million), about 1.1 times the size, while Neuronetics is growing revenue faster (+99.2% vs +22.2%).
KORU Medical Systems converts more of its revenue into profit, with a net margin of -6.4% versus -26.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KRMD | STIM |
|---|---|---|
| Share price | $3.19 | $1.25 |
| Market cap | $138.37M | $120.60M |
| 1-day change | -7.27% | +0.81% |
| YTD return | -45.09% | -9.42% |
| 1-year return | -33.26% | -4.58% |
| 5-year return | -12.60% | -69.66% |
| Forward P/E | 45.57 | — |
| EPS (TTM) | $-0.02 | $-0.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $41.13M | $149.16M |
| Revenue growth (YoY) | +22.23% | +99.17% |
| Net income (latest FY) | $-2.64M | $-39.00M |
| Gross margin | 62.26% | 48.48% |
| Operating margin | -7.23% | -21.08% |
| Net margin | -6.41% | -26.15% |
| 52-week high | $6.61 | $3.44 |
| 52-week low | $2.86 | $0.80 |
| Distance from 52-week high | -51.73% | -63.66% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +92.16% | +380.00% |
| Average volume | 223.45K | 1.76M |
| Shares outstanding | 43.38M | 96.48M |
| Employees | 73 | 658 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STIM has outperformed KRMD by 28.7 percentage points over the past year.
- KORU Medical Systems is more profitable, keeping -6.4 cents of every revenue dollar as net income versus -26.1 cents for Neuronetics.
- Neuronetics grew revenue faster in its latest fiscal year (+99.17% vs +22.23%).
About KORU Medical Systems
KRMD stock →KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.
Health Care · Medical/Dental Instruments · 73 employees
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 658 employees
KRMD vs STIM FAQ
Which is bigger, KORU Medical Systems or Neuronetics?
KORU Medical Systems (KRMD) is larger, with a market capitalization of $138.37M compared with $120.60M for Neuronetics (STIM).
Which stock has performed better over the past year, KRMD or STIM?
STIM returned -4.58% over the past 12 months, compared with -33.26% for KRMD (price return, excluding dividends). Past performance does not predict future results.
Are KORU Medical Systems and Neuronetics in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.